Clinical Trial Update: Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating allogeneic hematopoietic stem cell transplantation with TCRab+ T-cell and CD19+ B-cell depletion for monogenic or early-onset medical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation with TCRab+ T-cell and CD19+ B-cell depletion

Snippet

Sponsor: Stanford University | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING